[HTML][HTML] Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'
…, K Heinig-Menhard, I Koch, MG Stoleriu… - Nature …, 2021 - nature.com
The in vivo phenotypic profile of T cells reactive to severe acute respiratory syndrome (SARS)-CoV-2
antigens remains poorly understood. Conventional methods to detect antigen-…
antigens remains poorly understood. Conventional methods to detect antigen-…
Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery
…, X Wei, N Kneidinger, MG Stoleriu, G Burgstaller… - Journal of Controlled …, 2022 - Elsevier
While all the siRNA drugs on the market target the liver, the lungs offer a variety of currently
undruggable targets which could potentially be treated with RNA therapeutics. Hence, local, …
undruggable targets which could potentially be treated with RNA therapeutics. Hence, local, …
Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread
…, MG Stoleriu, V Grass, G Burgstaller… - Nucleic Acids …, 2022 - academic.oup.com
A promising approach to tackle the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
could be small interfering (si)RNAs. So far it is unclear, which viral replication steps …
could be small interfering (si)RNAs. So far it is unclear, which viral replication steps …
Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes
…, MG Stoleriu, A Popp, G Burgstaller… - Journal of Controlled …, 2022 - Elsevier
SARS-CoV-2 has been the cause of a global pandemic since 2019 and remains a medical
urgency. siRNA-based therapies are a promising strategy to fight viral infections. By targeting …
urgency. siRNA-based therapies are a promising strategy to fight viral infections. By targeting …
[HTML][HTML] Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts
…, J Beckers, O Eickelberg, GM Stoleriu… - European …, 2024 - Eur Respiratory Soc
Background Fibroblast-to-myofibroblast conversion is a major driver of tissue remodelling in
organ fibrosis. Distinct lineages of fibroblasts support homeostatic tissue niche functions, yet …
organ fibrosis. Distinct lineages of fibroblasts support homeostatic tissue niche functions, yet …
Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics
…, H Ma, AM Dworsky, A Sengupta, MG Stoleriu… - Science …, 2021 - science.org
Fibrogenic processes instigate fatal chronic diseases leading to organ failure and death.
Underlying biological processes involve induced massive deposition of extracellular matrix (…
Underlying biological processes involve induced massive deposition of extracellular matrix (…
[CITATION][C] Engineered receptor binding domain immunogens elicit pan-coronavirus neutralizing antibodies (preprint)
…, L Nowak, K Heinig, I Koch, MG Stoleriu… - 2020
[CITATION][C] Binding of SARS-CoV-2 spike protein to ACE2 is disabled by thiol-based drugs; evidence from in vitro SARS-CoV-2 infection studies.(preprint)
…, L Nowak, K Heinig, I Koch, MG Stoleriu… - 2020
[CITATION][C] Distant Residues Modulate the Conformational Opening in SARS-CoV-2 Spike Protein (preprint)
…, L Nowak, K Heinig, I Koch, MG Stoleriu… - 2020
[CITATION][C] Extended in vitro inactivation of SARS-CoV-2 by titanium dioxide surface coating (preprint)
…, L Nowak, K Heinig, I Koch, MG Stoleriu… - 2020
